René Reitermaier

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Friedrich Erhart, Johanna Buchroithner, René Reitermaier et al. · Acta Neuropathologica Communications · 2018 · 54 citations · Full text

Gliomasphere marker combinatorics: multidimensional flow cytometry detects <scp>CD</scp>44+/<scp>CD</scp>133+/<scp>ITGA</scp>6+/<scp>CD</scp>36+ signature

Friedrich Erhart, Bernadette Blauensteiner, Gabriel Zirkovits et al. · Journal of Cellular and Molecular Medicine · 2018 · 32 citations · Full text

αβγδ T cells play a vital role in fetal human skin development and immunity

René Reitermaier, Thomas Krausgruber, Nikolaus Fortelny et al. · The Journal of Experimental Medicine · 2021 · 25 citations · Full text

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors

Friedrich Erhart, Matthias Hackl, Hannes Hahne et al. · npj Vaccines · 2020 · 23 citations · Full text

Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy

Nina Zila, Ossia M. Eichhoff, Irene Steiner et al. · Clinical Cancer Research · 2023 · 21 citations